文献速递急性肾损伤

多中心开发与验证预测中重度AKI的多模态深度学习模型

Multicenter Development and Validation of a Multimodal Deep Learning Model to Predict Moderate to Severe AKI.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-04-15

本研究基于美国两家医疗中心2009至2022年成年住院患者数据,开发并验证了一种融合结构化数据与无结构化病历文本的多模态深度学习模型,用于预测48小时内发生≥2期AKI。模型在派生队列339998例次住院中开发,在时间验证队列84581例次中验证,预测≥2期AKI的AUC为0.88,优于仅用结构化数据的模型,外部验证结果相似。

要点

  • 多模态模型预测≥2期AKI的AUC为0.88,优于仅用结构化数据的模型。
  • 模型可较血清肌酐提前约2天识别将发生2期AKI的患者。
  • 预测接受KRT的AUC为0.93,外部验证结果相似。

核心结论

  • 融合结构化数据与无结构化病历文本的多模态深度学习模型能预测住院期间重度AKI的发生,性能优于仅用结构化数据的模型。

研究设计与样本

  • 多中心回顾性队列研究,纳入2009–2020年University of Wisconsin及2016–2022年University of Chicago Medicine的≥18岁住院成人。
  • 排除无记录血清肌酐、ESKD、入院SCr≥3.0 mg/dl、到达病房或ICU前已发生≥2期AKI、或48小时内需KRT者。
  • 派生队列339998例次住院,时间验证队列84581例次住院,采用中间融合深度学习循环神经网络架构预测48小时内≥2期AKI。

主要发现

  • 全队列中12748例(3%)发生≥2期AKI;这些患者年龄更大、男性更多、基线SCr更高、ICU比例更高(P<0.001)。
  • 多模态模型预测≥2期AKI的AUC(95%CI)为0.88(0.88–0.88),预测接受KRT的AUC为0.93(0.93–0.94)。
  • ≥2期AKI的精确率-召回率曲线下面积为0.20。
  • 多模态模型在所有结局上均优于仅基于结构化数据的模型,外部验证结果相似。

临床怎么用

  • 可利用融合结构化数据与病历文本的多模态模型早期识别中重度AKI高风险患者,为提前干预提供窗口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: We developed and validated a multimodal (structured and unstructured data) model to predict moderate to severe AKI using multicenter data. This multimodal AKI risk score accurately identifies patients who will develop stage 2 AKI over 2 days earlier than serum creatinine alone. The multimodal model performed better than a model based solely on structured data and performed similarly during temporal and site-based validation. BACKGROUND: Prior models for the early identification of AKI have used structured data (e.g., vital signs and laboratory values). We aimed to develop and validate a deep learning model to predict moderate to severe AKI by combining structured data and information from unstructured notes. METHODS: Adults (18 years or older) admitted to the University of Wisconsin (2009–2020) and the University of Chicago Medicine (2016–2022) were eligible for inclusion. Patients were excluded if they had no documented serum creatinine (SCr), ESKD, an admission SCr ≥3.0 mg/dl, developed ≥stage 2 AKI before reaching the wards or intensive care unit, or required dialysis (KRT) within the first 48 hours. Text from unstructured notes was mapped to standardized concept unique identifiers to create predictor variables, and structured data variables were also included. An intermediate fusion deep learning recurrent neural network architecture was used to predict ≥stage 2 AKI within the next 48 hours. This multimodal model was developed in the first 80% of the data and temporally validated in the next 20%. RESULTS: There were 339,998 admissions in the derivation cohort and 84,581 in the validation cohort, with 12,748 (3%) developing ≥stage 2 AKI. Patients with ≥stage 2 AKI were older, more likely to be male, had higher baseline SCr, and were more commonly in the intensive care unit (P < 0.001 for all). The multimodal model outperformed a model based only on structured data for all outcomes, with an area under the receiver operating characteristic curve (95% confidence interval) of 0.88 (0.88 to 0.88) for predicting ≥stage 2 AKI and 0.93 (0.93 to 0.94) for receiving KRT. The area under the precision-recall-curve for ≥stage 2 AKI was 0.20. The results were similar during external validation. CONCLUSIONS: We developed and validated a multimodal deep learning model using structured and unstructured data that predicts the development of severe AKI across the hospital stay for earlier intervention.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Koyner JL, Martin J, Carey KA, et al. Multicenter Development and Validation of a Multimodal Deep Learning Model to Predict Moderate to Severe AKI. Clin J Am Soc Nephrol. 2025. PMID: 40232856. doi:10.2215/CJN.0000000695

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。